hyperlipidaemia

Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes Metab.

Some of the causes of insulin resistance Ageing Hypoxia Endoplasmic reticulum stress Inflammation Fatty liver disease Lipotoxicity Genetic background Mitochondrial dysfunction Hyperinsu linaemia Obesity Hyperlipidaemia Oxidative stress

The results of analysis on detection rates of cardiac embolic cerebral infarction and clinical characteristics suggested that hyperlipidaemia will produce significant impacts on the detection rate of cardiac embolic cerebral infarction, and the detection rate of cardiac embolic cerebral infarction among patients with hyperlipidaemia was 64.7%, indicating clinical characteristics could affect the detection rate of cardiac embolic cerebral infarction.

Patients suffering from secondary hyperlipidaemia of any aetiology such as diabetes, hypothyroidism, hyperthyroidism, acute or chronic renal insufficiency, adrenal diseases, chronic liver diseases, malignancy, or hyperlipidaemia were excluded.

The objective of the present study was to investigate whether different metabolic risk factors and metabolic diseases, including obesity, central obesity, hyperlipidaemia, hypertension, diabetes, metabolic syndrome (Met-S), and nonalcoholic fatty liver disease (NAFLD), were associated with TN and their US imaging characteristics related to malignancy.

Hyperlipidaemia is a major modifiable cardiovascular risk and leads to serious morbidity and mortality.

In the present review, the efficacy of curcumin for improving a plasma lipid profile has been evaluated and compared with statins, a well-known class of medicines for treating hypercholesterolemia and hyperlipidaemia. Curcumin is presumably most effective in reducing triglyceride (TG), while statins are most efficient in lowering low-density lipoproteins-cholesterol (LDL-C).

Participants were to have had T2D for at least two years, be older than 25 years, and have had hyperlipidaemia and hyperglycaemia at study commencement despite treatment with statins and oral hypoglycaemic drugs for at least three months.

Hyperlipidaemia is diagnosed as abnormally elevated serum level of any or all lipids and/or lipoproteins.

Main risk factors for CS are smoking, hyperlipidaemia, advanced age, diabetes, chronic renal impairment and factors related to anaesthesia such as insufficient general anaesthesia, stimulation of the vagal nerve, hyperventilation, hypoxia, and use of large doses of catecholamines [8].

[6] Admixture of primary and secondary causes is especially evident in Fredrickson hyperlipidaemia types III, IV and V, where predisposing variant genes are stressed by diet, obesity with insulin resistance, hormonal derangements and alcohol intake.